Pneumocystis Pneumonia: The Daily PANCE Blueprint

The answer is A. Pneumocystis jirovecii pneumonia

Subacute dyspnea with a dry cough, a strikingly unremarkable lung examination, exertional desaturation, diffuse interstitial infiltrates, and a high LDH in a patient with a CD4 count under 200 is Pneumocystis jirovecii pneumonia. The organism is a fungus that was long misclassified as a protozoan — which is why it is treated with an antimicrobial rather than a conventional antifungal, and why the older name P. carinii still appears in the abbreviation PCP. The CD4 threshold of 200 cells/µL is the number to know: it defines the risk period, it triggers prophylaxis, and it should be the first thing you look for in any HIV stem. The clinical signature is the mismatch between how sick the lungs are and how normal they sound. The infection fills alveoli with a foamy exudate and thickens the interstitium, impairing gas exchange diffusely without producing the consolidation that generates crackles and bronchial breath sounds. That is why the examination is clean while the patient desaturates walking — and why ambulatory pulse oximetry is such a useful bedside test, since a resting saturation can be entirely reassuring. Radiographically the pattern is diffuse bilateral perihilar or “bat-wing” interstitial infiltrates; high-resolution CT shows ground-glass opacities and is more sensitive when the film looks normal. An elevated LDH is characteristic and tracks severity, and beta-D-glucan supports the diagnosis, but neither is specific. Definitive diagnosis requires visualizing the organism — induced sputum first, bronchoalveolar lavage if that is negative — using silver, Giemsa, or immunofluorescent stains, because Pneumocystis cannot be cultured. Treatment is trimethoprim-sulfamethoxazole for 21 days, first line and by a wide margin; alternatives for sulfa intolerance include primaquine plus clindamycin, atovaquone, or intravenous pentamidine. The highest-yield management point is the steroid rule: add adjunctive corticosteroids when the room-air PaO2 is below 70 mm Hg or the alveolar-arterial gradient exceeds 35 mm Hg, because treatment kills organisms and releases antigen, provoking an inflammatory surge that can worsen hypoxemia — steroids blunt it and reduce mortality. Prophylaxis with TMP-SMX begins at a CD4 below 200 and continues until the count is sustained above 200 for three months on antiretroviral therapy. Sorting the distractors: community-acquired bacterial pneumonia is abrupt over days with a productive cough, focal consolidation on film, and focal crackles or bronchial breath sounds; pulmonary tuberculosis also runs a subacute course with weight loss and night sweats but classically produces upper-lobe infiltrates with cavitation and is often atypical or disseminated at very low CD4 counts; pulmonary Kaposi sarcoma occurs in advanced HIV but presents with nodular infiltrates, pleural effusions, and characteristic endobronchial violaceous lesions, usually alongside mucocutaneous disease; and histoplasmosis in advanced HIV is typically disseminated, with fever, hepatosplenomegaly, pancytopenia, and mucosal ulcers, and follows Ohio and Mississippi River valley exposure.